Hao Zeng
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitor Renal Cell Carcinoma, Immunotherapy, Molecular Targeted Therapy | Phase 2 | 2024-08-01 |
| Active Not Recruiting | A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma Renal Cell Carcinoma, First-line Treatment, Non Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | 2023-11-17 |